The European Commission has announced the conclusion of a contract for the purchase of more than 100,000 doses of vaccines against monkeypox, detected in 19 Member States as well as in Norway and Iceland, reports France info.
First deliveries scheduled for the end of June
An agreement on the supply of 109,090 doses of third-generation monkeypox vaccines, on behalf of European countries, was therefore concluded on June 14 between the European Commission and the Danish company Bavarian Nordic. A new group order for vaccines in the EU which is inspired by the group purchases of anti-Covid vaccines, however on much smaller quantities.
Purchased on behalf of the new Hera health authority, created in the wake of the Covid-19 pandemic, the vaccines will be made available to the Twenty-Seven as well as to Norway and Iceland, with first deliveries of by the end of the month for priority countries, says the Commission. The amount of the contract was not disclosed.
The European medicines regulator (EMA) announced in early June that it had started discussions with this company, manufacturer of a vaccine against human smallpox, eradicated for more than 40 years, to possibly extend its use against monkeypox.
Towards vaccination of contact cases
The European Center for Disease Control and Prevention has recommended early post-exposure vaccination to prevent the disease or make its development less serious, recalls Brussels. Getting vaccinated quickly after being exposed to the virus can help prevent the disease or make its development less serious, justified the European Commission on Tuesday.
In the United States, the administration of Joe Biden placed an order on June 10 for 500,000 additional doses of the Jynneos vaccine against monkeypox, the country also moving towards the vaccination of contact cases against this disease, according to the recommendation of the Centers for Disease Control and Prevention (CDC).
See also: Monkey pox: Joe Biden orders 500,000 more vaccines
The human smallpox vaccine can cause serious side effects
A surprising strategy. As Professor Christian Perronne, former head of the infectious diseases department at Garches hospital, pointed out in an interview given to Ligne Droite on June 6, the monkeypox virus, a cousin of human smallpox, has existed for millennia. Characterized by extremely low mortality, this rare disease originating in Africa, the symptoms of which last two to three weeks, is very little transmissible to humans. In general, it heals spontaneously. Therefore, using the vaccine against human smallpox, known for the serious side effects it can cause, is nonsense, according to the doctor who denounces the amalgamation between human smallpox and monkey pox operated by the tone of the mainstream media discourse.
Remarks that echo those of Professor Martin Zizi, former epidemiological director within the Belgian Defense Department, who confided to us during a recent debriefing of his distrust of the vaccination strategy against monkeypox: “A false solution to a non-problem,” he said.
See also: “Monkey pox is a non-issue” Dr Martin Zizi (first part)